神经外科患者胃肠动力障碍与颅内出血、阿片类药物使用及脑干水肿相关
回顾性研究纳入69例ICU停留>4天的神经外科成人患者,胃轻瘫48例(69.6%)、便秘67例(97.1%)。脑干水肿患者首次排便时间晚于无水肿者(8 vs 3.5天,P<0.001)。多因素分析中CNS出血(OR 5.1,95%CI 1.26-20.8,P=0.02)、阿片>19.3 ME/天(OR 5.37,95%CI 1.1-27.1,P=0.04)及脑干水肿(OR 4.9,95%CI 1.1-21.6,P=0.04)与胃肠动力障碍相关。ROC显示>6.78 ME/天预测胃肠动力障碍的敏感性89.5%、特异性72.7%。
要点
- 脑干水肿患者首次排便中位时间8天(IQR 5.25-9.75),无水肿者3.5天(IQR 2.25-4),P<0.001。
- 多因素分析:CNS出血与胃肠动力障碍相关(OR 5.1,95%CI 1.26-20.8,P=0.02),为最重要单一因素。
- 阿片用量>19.3 ME/天与胃肠动力障碍相关(OR 5.37,95%CI 1.1-27.1,P=0.04)。
- ROC分析示阿片>6.78 ME/天预测胃肠动力障碍敏感性89.5%、特异性72.7%(AUC 0.784,95%CI 0.67-0.88,P=0.001)。
- 生存差与低GCS(ρ=-520,P<0.001)、CNS出血(ρ=0.393,P<0.001)、心脏病(ρ=0.279,P<0.001)及入院心跳呼吸骤停(ρ=0.315,P<0.001)相关,与胃肠动力障碍无关(ρ=0.175,P=0.402)。
适用人群与场景
- 在ICU停留超过4天的神经外科成人患者(69例)。
诊断标准与关键阈值
- 胃轻瘫定义为每日胃残余量>250 mL。
- 便秘定义为ICU停留期间≥3天无排便。
研究设计与关键结果
- 回顾性研究:筛查207例神经外科患者,纳入69例ICU停留>4天的成人患者;胃轻瘫48例(69.6%),便秘67例(97.1%),应激性溃疡4例(5.8%)。
- 脑干水肿患者57例(82.6%),首次排便时间8天(IQR 5.25-9.75),无水肿者3.5天(IQR 2.25-4),P<0.001。
- 多因素分析:CNS出血OR 5.1(95%CI 1.26-20.8,P=0.02),阿片>19.3 ME/天OR 5.37(95%CI 1.1-27.1,P=0.04),脑干水肿OR 4.9(95%CI 1.1-21.6,P=0.04)。
- ROC分析:阿片>6.78 ME/天预测胃肠动力障碍,敏感性89.5%,特异性72.7%(95%CI 0.67-0.88,AUC 0.784,Youden指数0.62,P=0.001)。
- 生存差相关因素:低GCS(ρ=-520,P<0.001)、CNS出血(ρ=0.393,P<0.001)、心脏病(ρ=0.279,P<0.001)、入院心跳呼吸骤停(ρ=0.315,P<0.001);与胃肠动力障碍无关(ρ=0.175,P=0.402)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,进一步研究阿片类与非阿片类镇静可能区分急性脑损伤与药物对胃肠动力障碍的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Gastrointestinal (GI) motility disorders may be directly associated with the intensity of acute brain injury, edema of the brainstem, and opioid use in neurosurgical patients.
METHODS: In this retrospective study, patient demographic characteristics, computed tomography (CT) scans, the occurrence of gastroparesis, constipation, and opioid use were registered during the intensive care unit (ICU) stay and correlated with days of mechanical ventilation, length of ICU stay, and survival. Gastroparesis was defined as residual gastric volume > 250 mL per day, and constipation was defined as the absence of stool for 3 days or more during the ICU stay.
RESULTS: Of 207 neurosurgical patients screened, 69 adult patients who spent more than 4 days in the ICU were included in the study. Gastroparesis was observed in 48 (69.6%) patients, constipation was observed in 67 (97.1%) patients, and stress ulcers were observed in 4 (5.8%) patients. Patients with brainstem edema (n = 57, 82.6%) had the first stool evacuation later compared with patients with no edema (8 [interquartile range (IQR) 5.25-9.75] vs. 3.5 [IQR 2.25-4] days; P < 0.001). In the logistic regression analysis, factors that were associated with GI dysmotility were central nervous system (CNS) bleeding (odds ratio [OR] 5.1, 95% confidence interval [CI] 1.26-20.8, P = 0.02), opioid use > 19.3 morphine equivalents (ME) per day (OR 5.37, 95% CI 1.1-27.1, P = 0.04), and brainstem edema (OR 4.9, 95% CI 1.1-21.6, P = 0.04). A receiver operating characteristic curve analysis confirmed that the cutoff value of > 6.78 ME per day was a good predictor determining GI dysmotility, with 89.5% sensitivity and 72.7% specificity (95% CI 0.67-0.88, area under the curve 0.784, Youden index 0.62, P = 0.001). Poor survival correlated with lower Glasgow Coma Score values (ρ = - 520, P < 0.001), CNS bleeding (ρ = 0.393, P < 0.001), associated cardiac diseases (ρ = 0.279, P < 0.001), and cardiorespiratory arrest on admission (ρ = 0.315, P < 0.001), but not with GI dysmotility (ρ = 0.175, P = 0.402).
CONCLUSIONS: Significant correlation was registered between brainstem edema, gastrointestinal dysmotility, and opioids. CNS bleeding was the most important single factor influencing GI dysmotility. Further studies with opioid and nonopioid sedation may distinguish the influence of acute brain lesions versus drugs on GI dysmotility.
参考来源
- Kunovac F, Cicvaric A, Robba C, et al. Gastrointestinal Motility Disorders Correlate with Intracranial Bleeding, Opioid Use, and Brainstem Edema in Neurosurgical Patients. Neurocrit Care. 2023. PMID: 36788178. doi:10.1007/s12028-023-01678-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。